Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2020

01-02-2020 | Pneumonia | Case report

Ceftriaxone

Acute cholangitis and pseudolithiasis: case report

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Yamada S, et al. Rapid formation of large pseudostones and acute cholangitis caused by ceftriaxone treatment for bacterial pneumonia in a patient on kidney transplantation: potential risk of ceftriaxone use in patients with decreased kidney function. CEN Case Reports 9: 87-88, 17 Sep 2019. Available from: URL: http://​doi.​org/​10.​1007/​s13730-019-00418-z CrossRef
Metadata
Title
Ceftriaxone
Acute cholangitis and pseudolithiasis: case report
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-75175-1

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Isotretinoin/testosterone

Case report

Follitropin α/menotropin

Case report

Epoprostenol

Case report

Ferric-derisomaltose/ferumoxytol

Case report

Heparin/warfarin

Case report

Metronidazole